Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study.
Reiter A, Bengesser SA, Hauschild AC, Birkl-Töglhofer AM, Fellendorf FT, Platzer M, Färber T, Seidl M, Mendel LM, Unterweger R, Lenger M, Mörkl S, Dalkner N, Birner A, Queissner R, Hamm C, Maget A, Pilz R, Kohlhammer-Dohr A, Wagner-Skacel J, Kreuzer K, Schöggl H, Amberger-Otti D, Lahousen T, Leitner-Afschar B, Haybäck J, Kapfhammer HP, Reininghaus E. Reiter A, et al. Among authors: kreuzer k. Nutrients. 2020 Aug 26;12(9):2575. doi: 10.3390/nu12092575. Nutrients. 2020. PMID: 32858844 Free PMC article. Clinical Trial.
Sleep and Microbiome in Psychiatric Diseases.
Wagner-Skacel J, Dalkner N, Moerkl S, Kreuzer K, Farzi A, Lackner S, Painold A, Reininghaus EZ, Butler MI, Bengesser S. Wagner-Skacel J, et al. Among authors: kreuzer k. Nutrients. 2020 Jul 23;12(8):2198. doi: 10.3390/nu12082198. Nutrients. 2020. PMID: 32718072 Free PMC article. Review.
The PROVIT Study-Effects of Multispecies Probiotic Add-on Treatment on Metabolomics in Major Depressive Disorder-A Randomized, Placebo-Controlled Trial.
Kreuzer K, Reiter A, Birkl-Töglhofer AM, Dalkner N, Mörkl S, Mairinger M, Fleischmann E, Fellendorf F, Platzer M, Lenger M, Färber T, Seidl M, Birner A, Queissner R, Mendel LS, Maget A, Kohlhammer-Dohr A, Häussl A, Wagner-Skacel J, Schöggl H, Amberger-Otti D, Painold A, Lahousen-Luxenberger T, Leitner-Afschar B, Haybaeck J, Habisch H, Madl T, Reininghaus E, Bengesser S. Kreuzer K, et al. Metabolites. 2022 Aug 21;12(8):770. doi: 10.3390/metabo12080770. Metabolites. 2022. PMID: 36005642 Free PMC article.
Gut Microbiome Composition and Its Association with Sleep in Major Psychiatric Disorders.
Mairinger M, Maget A, Wagner-Skacel J, Mörkl S, Dalkner N, Hellinger T, Birner A, Fellendorf FT, Platzer M, Kreuzer K, Queissner R, Reininghaus B, Lenger M, Fabisch K, Fitz W, Kohlhammer-Dohr A, Krammer A, Holl AK, Painold A, Häussl A, Stross TM, Schmiedhofer F, Tmava-Berisha A, Pahsini K, Marinschek S, Wenninger J, Hamm C, Pilz R, Lehofer M, Amouzadeh-Ghadikolai O, Horvath A, Kainz G, Gallé B, Dinan TG, Butler MI, Reininghaus E, Bengesser S. Mairinger M, et al. Among authors: kreuzer k. Neuropsychobiology. 2023;82(4):220-233. doi: 10.1159/000530386. Epub 2023 Jun 15. Neuropsychobiology. 2023. PMID: 37321188 Free article.
Impaired implicit learning in adults with anorexia nervosa.
Wiener M, Bengesser SA, Wagner-Skacel J, Haidacher FNA, Lahousen-Luxenberger T, Wenninger J, Hasiba-Seebacher K, Fellendorf FT, Painold A, Kreuzer K, Butler M, Lackner S, Pilz R, Mörkl S. Wiener M, et al. Among authors: kreuzer k. Int J Eat Disord. 2024 Jan;57(1):195-200. doi: 10.1002/eat.24075. Epub 2023 Oct 23. Int J Eat Disord. 2024. PMID: 37870449
PROVIT-CLOCK: A Potential Influence of Probiotics and Vitamin B7 Add-On Treatment and Metabolites on Clock Gene Expression in Major Depression.
Kreuzer K, Birkl-Toeglhofer AM, Haybaeck J, Reiter A, Dalkner N, Fellendorf FT, Maget A, Platzer M, Seidl M, Mendel LM, Lenger M, Birner A, Queissner R, Mairinger M, Obermayer A, Kohlhammer-Dohr A, Stross TM, Häussl A, Hamm C, Schöggl H, Amberger-Otti D, Painold A, Lahousen-Luxenberger T, Leitner-Afschar B, Färber T, Mörkl S, Wagner-Skacel J, Meier-Allard N, Lackner S, Holasek S, Habisch H, Madl T, Reininghaus E, Bengesser SA. Kreuzer K, et al. Neuropsychobiology. 2024 May 22:1-17. doi: 10.1159/000538781. Online ahead of print. Neuropsychobiology. 2024. PMID: 38776887
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial.
Fürstenau M, Giza A, Weiss J, Kleinert F, Robrecht S, Franzen F, Stumpf J, Langerbeins P, Al-Sawaf O, Simon F, Fink AM, Schneider C, Tausch E, Schetelig J, Dreger P, Böttcher S, Fischer K, Kreuzer KA, Ritgen M, Schilhabel A, Brüggemann M, Stilgenbauer S, Eichhorst B, Hallek M, Cramer P. Fürstenau M, et al. Among authors: kreuzer ka. Blood. 2024 Apr 15:blood.2023022730. doi: 10.1182/blood.2023022730. Online ahead of print. Blood. 2024. PMID: 38620072
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial.
Cramer P, von Tresckow J, Fink AM, Robrecht S, Giza A, Tausch E, Müller L, Knauf W, Zingerle M, Al-Sawaf O, Langerbeins P, Fischer K, Kreuzer KA, Kneba M, Wendtner CM, Stilgenbauer S, Eichhorst B, Hallek M. Cramer P, et al. Among authors: kreuzer ka. Am J Hematol. 2024 Jun;99(6):1192-1195. doi: 10.1002/ajh.27304. Epub 2024 Apr 5. Am J Hematol. 2024. PMID: 38578022 Clinical Trial. No abstract available.
268 results